301096 Stock Overview
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥39.70 |
| 52 Week High | CN¥77.78 |
| 52 Week Low | CN¥33.57 |
| Beta | 0.29 |
| 1 Month Change | -0.33% |
| 3 Month Change | -2.36% |
| 1 Year Change | -38.34% |
| 3 Year Change | -54.19% |
| 5 Year Change | n/a |
| Change since IPO | -60.72% |
Recent News & Updates
We Believe That Hangzhou Bio-Sincerity Pharma-TechLtd's (SZSE:301096) Weak Earnings Are A Good Indicator Of Underlying Profitability
Nov 04
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SZSE:301096) Soars 30% But It's A Story Of Risk Vs Reward
Sep 30Recent updates
We Believe That Hangzhou Bio-Sincerity Pharma-TechLtd's (SZSE:301096) Weak Earnings Are A Good Indicator Of Underlying Profitability
Nov 04Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SZSE:301096) Soars 30% But It's A Story Of Risk Vs Reward
Sep 30Market Cool On Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s (SZSE:301096) Earnings Pushing Shares 27% Lower
Jul 24Solid Earnings May Not Tell The Whole Story For Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096)
Apr 29Should You Be Adding Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096) To Your Watchlist Today?
Mar 14Shareholder Returns
| 301096 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | -0.5% | -2.9% | -1.0% |
| 1Y | -38.3% | -18.5% | 10.8% |
Return vs Industry: 301096 underperformed the CN Life Sciences industry which returned -18.5% over the past year.
Return vs Market: 301096 underperformed the CN Market which returned 10.8% over the past year.
Price Volatility
| 301096 volatility | |
|---|---|
| 301096 Average Weekly Movement | 9.5% |
| Life Sciences Industry Average Movement | 10.2% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 13.0% |
| 10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 301096 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 301096's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 1,786 | Jinfang Lou | www.hzbio-s.com |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. operates as a pharmaceutical technology research and development and services company in China. The company primarily provides drug research and development services; and the transformation of research and development technology results for various pharmaceutical, as well as pharmaceutical research and development investment companies.
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Fundamentals Summary
| 301096 fundamental statistics | |
|---|---|
| Market cap | CN¥4.32b |
| Earnings (TTM) | CN¥212.13m |
| Revenue (TTM) | CN¥1.03b |
20.3x
P/E Ratio4.2x
P/S RatioIs 301096 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301096 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.03b |
| Cost of Revenue | CN¥399.02m |
| Gross Profit | CN¥626.10m |
| Other Expenses | CN¥413.96m |
| Earnings | CN¥212.13m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.96 |
| Gross Margin | 61.08% |
| Net Profit Margin | 20.69% |
| Debt/Equity Ratio | 21.6% |
How did 301096 perform over the long term?
See historical performance and comparisonDividends
0.8%
Current Dividend Yield15%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 11:43 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jiabo Zhang | Guosen Securities Co., Ltd. |
| Yuan Yuan Sun | Industrial Securities Co. Ltd. |
| Chaoze Zhou | Minsheng Securities Co. |